| Name | Title | Contact Details |
|---|
Crouse Hospital has been caring for generations of Central New Yorkers since 1887. Our mission is to provide the best in patient care by exceeding the expectations of our patients and to promote community health. A private, not-for-profit hospital, Crouse is licensed for 506 acute-care beds and 57 bassinets. We serve more than 23,000 inpatients, 66,000 emergency services patients and more than 250,000 outpatients a year from a 15-county area in Central and Northern New York.
Empowering the public through free, convenient self-service health care. Formerly SoloHealth.
Flyana.Com Inc is a Anahola, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded by identical twins, Rose Cook and Lynn Faughey, The FlexPro Group is a specialty consulting firm, focused on delivering project management expertise to companies in the Life Sciences. Since 2008, FlexPro has been recognized as a premier provider of project management consulting services to this industry. For the 3rd year in a row, FlexPro was recognized by Inc. Magazine as one of America`s fastest-growing private companies: #859 (2014), #288 (2013) and #104 (2012). Also ranked 6th on the Philadelphia 100 lists of fastest growing privately-held companies (both in 2013 and 2012). Ranked among the Top 25 Management Consulting Firms in Philadelphia Business Journal`s "The List" (2017).
Our name, Monogram, symbolizes the personalized focus of our services. While the application of the latest technology and data science is critical to our success, we never lose sight that healthcare is ultimately about trusted individual relationships between healthcare professionals and their patients. Unfortunately, individuals living with advanced CKD and ESRD are negatively impacted by well entrenched systematic forces such as perverse economic incentives, poor adherence to evidence-based care, and a lack of sensitivity to the negative impacts of social determinants of health. The 21st Century Cures Act is a seminal piece of legislation designed to shift individuals living with ESRD from FFS Medicare into managed care and reverse decades and decades of sub-optimal outcomes. Monogram was born with a vision to serve health plans and other sponsors of health care and solve for these systemic problems. Our mission is to improve clinical outcomes by predicting the onset of CKD and ESRD, slowing its progression, and reducing hospitalizations, morbidity and mortality. We are founded and operated by a core group of former government programs health plan executives, including our CEO, Michael Uchrin, a world-renown nephrologist and author of over 200 published pieces of research, Dr. Raymond Hakim, and former US Senator Bill Frist M.D., a retired cardiac surgeon and recognized leader for improving the quality of care provided to human beings across the world. We welcome all stakeholders in the CKD | ESRD ecosystem to join us in our mission to measurably improve outcomes for individuals living with these conditions.